Sarcopenia, peripheral neuropathy, and peripheral arterial disease in patients with diabetes mellitus under hemodialysis

被引:0
|
作者
Bustamante Hernandez, Martha Beatriz [1 ]
Garduno Garcia, Jose de Jesus [1 ]
Montenegro Morales, Laura Patricia [2 ]
Camarillo Romero, Eneida del Socorro [2 ]
Huitron Bravo, Gerardo [2 ]
Camarillo Romero, Maria del Socorro [2 ]
机构
[1] Univ Autonoma Estado Mexico UNAM, Fac Med, Mexico City, DF, Mexico
[2] Univ Autonoma Estado Mexico UNAM, Fac Quim, Mexico City, DF, Mexico
来源
关键词
sarcopenia; peripheral neuropathy; peripheral arterial disease; diabetes mellitus; renal dialysis; hemodialysis; TYPE-2; DIAGNOSIS; CONSENSUS; EXERCISE; INDEX;
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Sarcopenia is characterized by loss of strength and muscle mass. Patients with diabetes mellitus who are under hemodialysis treatment show decreased physical activity and changes in their food intake, which also leads to the presence of sarcopenia. On the other hand, peripheral neuropathy and peripheral arterial disease commonly appear as chronic complications of diabetes mellitus. Methods: A cross-sectional, observational study was carried out in diabetes mellitus patients on hemodialysis. For the assessment of sarcopenia, muscle strength, physical performance and muscle mass percentage were measured. Muscle strength was calculated with a dynamometer, while physical performance was evaluated in seconds by means of a walk test with a stopwatch; muscle mass percentage was obtained using a scale with bioelectrical impedance. Sarcopenia was considered severe when there was low muscle strength and percentage in addition to low physical performance. Peripheral neuropathy was assessed by exploring touch and pressure sensibility with the Semmes-Weinstein monofilament test and deep sensibility with a 128 Hz tuning fork. The ankle-brachial index was the measurement taken for the peripheral arterial disease classification. Results: The final analysis was performed with 33 patients, whose time on hemodialysis was 3.57 +/- 2.56 years. The prevalence of severe sarcopenia and sarcopenia was 90.8% and that of pre-sarcopenia was 9% of all patients. On the other hand, 78.1% were found to be patients with loss of deep sensibility, while the percentage of patients with loss of sensibility to pressure and touch was 54.5%. A correlation was found between the sarcopenia parameters and the time of evolution of renal failure and age. Conclusion: Sarcopenia occurs, in its different stages, in practically all diabetes mellitus patients undergoing hemodialysis; there is a relationship with the patient's age and hemodialysis time.
引用
收藏
页码:151 / 158
页数:8
相关论文
共 50 条
  • [41] Effect of Angioplasty on Sarcopenia in Peripheral Arterial Occlusive Disease Patients
    Kim, Dong Hyun
    Park, Je Hyung
    Mun, Jin Ho
    Lee, Sang Su
    JOURNAL OF VASCULAR SURGERY, 2022, 75 (06) : E220 - E221
  • [42] The prevalence of peripheral neuropathy in hemodialysis patients
    Mambelli, Emanuele
    Barrella, Massimo
    Facchini, Maria Grazia
    Mancini, Elena
    Sicuso, Carmelo
    Bainotti, Serena
    Formica, Marco
    Santoro, Antonio
    CLINICAL NEPHROLOGY, 2012, 77 (06) : 468 - 475
  • [43] Role of the calf pain in patients with diabetes with or without neuropathy and or peripheral arterial disease.
    Bax, G
    Piarulli, F
    Fagherazzi, C
    Cospite, A
    Fedele, D
    DIABETES, 1997, 46 : 1168 - 1168
  • [44] Treating peripheral arterial disease in patients with diabetes
    Hittel, N
    Donnelly, R
    DIABETES OBESITY & METABOLISM, 2002, 4 : S26 - S31
  • [45] Diabetes care for patients with peripheral arterial disease
    Heikkinen, M.
    Salmenpera, M.
    Lepantalo, A.
    Lepantalo, M.
    EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, 2007, 33 (05) : 583 - 591
  • [46] Characteristics of Plantar Pressure Distribution in Diabetes with or without Diabetic Peripheral Neuropathy and Peripheral Arterial Disease
    Cao, Zijun
    Wang, Fang
    Li, Xuemei
    Hu, Jun
    He, Yaoguang
    Zhang, Jianguo
    JOURNAL OF HEALTHCARE ENGINEERING, 2022, 2022
  • [47] DIABETES-MELLITUS, VESTIBULOPATHY AND PERIPHERAL NEUROPATHY
    HART, CW
    GELTMAN, CL
    SCHUPBACH, J
    VERTIGO, NAUSEA, TINNITUS AND HYPOACUSIA IN METABOLIC DISORDERS, 1988, 791 : 371 - 374
  • [48] PERIPHERAL NEUROPATHY IN MOUSE DIABETES-MELLITUS
    HANKER, JS
    YATES, PE
    CARSON, KA
    CHAMPION, MS
    AMBROSE, WW
    JOURNAL OF DENTAL RESEARCH, 1976, 55 : B109 - B109
  • [49] Peripheral neuropathy in the hands of people with diabetes mellitus
    Ennis, Samantha L.
    Galea, Mary P.
    O'Neal, David N.
    Dodson, Michael J.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2016, 119 : 23 - 31
  • [50] Peripheral neuropathy may be a potential risk of cardiovascular disease in diabetes mellitus
    Margariti, Andriana
    HEART, 2014, 100 (23) : 1823 - 1824